Gantofiban

CAS No. 183547-57-1

Gantofiban( —— )

Catalog No. M36175 CAS No. 183547-57-1

Gantofiban is a glycoprotein IIb/IIIa (GP IIb/IIIa) antagonist used in the treatment of cardiovascular disease and may be used to study thrombosis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 192 In Stock
10MG 274 In Stock
25MG 430 In Stock
50MG 600 In Stock
100MG 820 In Stock
200MG 1097 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Gantofiban
  • Note
    Research use only, not for human use.
  • Brief Description
    Gantofiban is a glycoprotein IIb/IIIa (GP IIb/IIIa) antagonist used in the treatment of cardiovascular disease and may be used to study thrombosis.
  • Description
    Gantofiban is a glycoprotein IIb/IIIa (GP IIb/IIIa) antagonist used in the treatment of cardiovascular disease and may be used to study thrombosis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Integrin
  • Recptor
    Integrin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    183547-57-1
  • Formula Weight
    447.48
  • Molecular Formula
    C21H29N5O6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1N(C[C@@H](CN2CCN(CC(OCC)=O)CC2)O1)C3=CC=C(C(NC(OC)=O)=N)C=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Valategrast hydrochl...

    Valategrast hydrochloride is a potent, α4β1 (VLA-4) and α4β7 dual antagonist.

  • SF0166

    SF0166 is a topically administered αvβ3 integrin antagonist, inhibits integrin-ligand interactions with IC50 of 0.6 nM to 13 nM for human αvβ3, αvβ6, and αvβ8.

  • A 286982

    A 286982 is an inhibitor that blocks the integrin-ligand interaction between leukocyte function-associated antigen-1 (LFA-1) and intercellular adhesion molecule-1.